XBiotech Inc (XBIT) gains 1.00% for July 21

Equities Staff  |

XBiotech Inc (NASDAQ: XBIT) shares gained 1.00%, or $0.16 per share, to close Wednesday at $16.11. After opening the day at $16.00, shares of XBiotech fluctuated between $16.48 and $15.79. 46,828 shares traded hands a decrease from their 30 day average of 153,995. Wednesday's activity brought XBiotech’s market cap to $483,039,034.

XBiotech is headquartered in Austin, Texas..

About XBiotech Inc

XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally occurring antibodies from patients with immunity to certain diseases. Utilizing natural human immunity as a source of new medicines offers the potential to redefine the standards of care for a wide range of diseases.

Visit XBiotech Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on XBiotech Inc and to follow the company’s latest updates, you can visit the company’s profile page here: XBiotech Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content